“Curative Conversion of Metastatic Gastric Cancer After Pembrolizumab-Trastuzumab-Based Therapy in a PD-L1-Negative, HER2-Positive Patient: A Case Report and Literature Review”, MJCR, vol. 1, no. 1, pp. 30–38, May 2026, doi: 10.64913/mmrmjcr.v1i1.21.